British scientists urged European countries to take note on Wednesday of interim data showing what they described as "remarkable" effectiveness of a single dose of Pfizer's or AstraZeneca's COVID-19 vaccines in frail and elderly people. The results from a surveillance project called AvonCAP, funded by Pfizer, found that one dose of the Pfizer-BioNTech or AstraZeneca shot was